1.25 / AMA PRA Category 1 CreditsTM 1.25 / Nursing (NCPD) Contact Hours
Jointly provided by Haymarket Medical Education and The American Psychiatric Nurses Association
In Collaboration With
This activity is supported by an educational grant provided by Allergan.
Keeping up with the peer-reviewed literature related to bipolar depression and schizophrenia adds yet another layer to the many challenges of treating patients with these conditions. In this virtual journal club, experts help by reviewing a carefully curated selection of recent relevant publications. The faculty share their insights on the strengths and weaknesses of these papers and their perspectives on how the findings may apply in day-to-day patient care.
Psychiatrists, primary care physicians, nurse practitioners, advanced practice registered nurses, and physician assistants who care for patients with mental health disorders in psychiatric or primary care settings
At the conclusion of this activity, participants should be better able to:
Apply knowledge of the relative benefits and risks of available and emerging therapies when treating bipolar depression
Recognize the burden of disease associated with negative symptoms in schizophrenia and assess recent evidence regarding its treatment
Explain the clinical relevance of dopamine D3 receptors in treating bipolar depression, schizophrenia, and other psychiatric illnesses
Conflict Of Interest Disclosure Policies
In accordance with the ACCME Standards for Commercial Support, Haymarket Medical Education (HME) and the American Psychiatric Nurses Association (APNA) require that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. HME and APNA resolve all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all their educational activities.
Roger S. McIntyre, MD, FRCPC – Chair Professor of Psychiatry and Pharmacology University of Toronto Toronto, Ontario, Canada Chairman and Executive Director Brain and Cognition Discovery Foundation Toronto, Ontario, Canada
Dr. McIntyre is on the speakers’ bureaus of Allergan, Janssen, Lundbeck, Minerva, Neurocrine Biosciences Inc., Otsuka, Pfizer, Shire, Sunovion, and Takeda. He is also a consultant for Allergan, Janssen, Lundbeck, Minerva, Neurocrine Biosciences Inc., Otsuka, Pfizer, Purdue, Shire, Sunovion, and Takeda and has received research funding or grants from the CIHR/GACD/Chinese National Natural Research Foundation and the Stanley Medical Research Institute.
Gregory W. Mattingly, MD Associate Clinical Professor Washington University in St. Louis President St. Charles Psychiatric Associates St Louis, MO
Dr. Mattingly has no relevant financial relationships to disclose.
Dawn M. Vanderhoef, PhD, DNP, PMHNP-BC, FAANP Associate Professor of Psychiatry Academic Director, Psychiatric-Mental Health Nurse Practitioner Program Vanderbilt University School of Nursing Nashville, TN
Dr. Vanderhoef is on the speakers’ bureau of Neurocrine Biosciences, Inc.
Accredited Provider Disclosures
Haymarket Medical Education and American Psychiatric Nurses Association staff involved in the planning and content review of this activity have no relevant financial relationships to disclose.
AMA PRA Category 1 Credit(s)TM
Haymarket Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
HME designates this enduring material for a maximum of 1.25 AMA PRA Category 1 CreditsTM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE Contact Hour(s)
The American Psychiatric Nurses Association is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
This activity has been approved for 1.25 Nursing Continuing Education contact hours by the APNA.
Additional Credit Information
Physician Assistant Continuing Education AAPA accepts certificates of participation for educational activities approved for AMA PRA Category 1 CreditTM from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 1.25 Category 1 Credits for completing this activity.
Disclosure of Unlabeled Use
This CME/CE activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options for a specific patient’s medical condition.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Allergan, Inc., HME, or the APNA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
To obtain credit, a score of 70% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCMETM within your Profile/CME History, which you can access at any time.